Here we go.
The efficacy of the Pfizer/BioNTech Vaccine Efficacy has slipped to 84%.
It was initially thought to be 96% effective.
STAT: Efficacy of Pfizer/BioNTech Covid vaccine slips to 84% after six months, data show
— Josh Caplan (@joshdcaplan) July 28, 2021
The efficacy of the Covid-19 vaccine developed by Pfizer and BioNTech fell from 96% to 84% over six months, according to data released Wednesday, a decline that could fuel Pfizer’s case that a third dose will eventually be required.
The data, released in a preprint that has not been reviewed by outside scientists, suggest the vaccine was 91% effective overall at preventing Covid-19 over the course of six months.
In the ongoing study, which enrolled more than 44,000 volunteers, the vaccine’s efficacy in preventing any Covid-19 infection that causes even minor symptoms appeared to decline by an average of 6% every two months after administration. It peaked at more than 96% within two months of vaccination and slipped to 84% after six months.
Of course, rather than anyone questioning Pfizer and BioNTech they are now pushing for a third dose.
The Palmieri Report is a Pro-America News Outlet founded by Jacob Palmieri four years ago at the age of 19. Since its founding, it has gotten over 2M pages views and over 20k followers. The Palmieri Report is dedicated to giving people the truth so that they can form their own informed political opinions.